FDA Investigator Donna Mwilliams Hill
Donna Mwilliams Hill has inspections in 4 countries as of 13 Oct 2023. Donna Mwilliams Hill has collaborated with a combined 2790 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
17
Last Inspection Date:
13 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland,
France,
United States of America,
Germany
Co-Investigator(s):
Aaron J Adler,
Alan P Kurtzberg,
Albinus D'sa, PhD,
Alexandra B Pitkin,
Alexandria L Capuano,
Amanda L Fyles,
Amir Alavi,
Anastasia M Shields,
Annemarie Bodnar,
April P Shaw,
Arie C Menachem,
Arsen Karapetyan,
Babajide Michael Osunsanmi,
Belinda E Clifton,
Binh T Nguyen,
Bonnie I Needleman,
Bowman,
Brian J Ryan,
Brien C Fox,
Bruce H Mccullough,
Bush,
Carla A Norris,
Carla J Lundi,
Carol B Czerniak,
Carolina D Vasquez,
Carr Sharpe,
Carrie A Hughes,
Caryn M Mcnab,
Chelsea N Sealey,
Christopher R Czajka,
Clotia Cabbey Mensah,
David Y Hernandez,
Deborah A Greco,
Deborah G Park,
Dennis Cantellops Paite,
Diane Cvan Leeuwen,
Donna Ltartaglino Besone,
Dr. Chunchang Fang,
Dyana K Stone,
Elaine A Bunch,
Esther B Gamallo Herrera,
Evelyn Wong,
Gabriel M Guevarra,
Gale E Ryan,
Gene D Arcy,
Gerald B Seaborn, Jr,
Grace P Santos,
Heidy C Perales,
James I Giefer,
James M Timper Jr,
James R Fleckenstein,
Jamie M Du,
Jane S Wernberg,
Janis R Armedoriz,
Jeff M Uriarte,
Jennifer D Hollstrom,
Jennifer M Gogley,
Jinnie Kokiatkulkij,
Joan A Loreng,
Jocelyn E Massey,
Joey V Quitania,
John A Gonzalez,
John P Jorgensen,
Joseph C Yen,
Judy C Nepsa,
Julie A Rorberg,
Julie A Stocklin,
Justine Tomasso,
Ka L Wong,
Karen E D'orazio,
Katherine E Jacobitz,
Kathy Chiu,
Kathy Kuo,
Kelley,
Kelvin X Sanders,
Kenneth H Williams,
Kevin A Gonzales,
Kevin A Gonzalez,
Kevin Lee,
Kham Phommachanh,
Kim Lthomas Cruse,
Kim Thomas Chase,
Kirtida Patel,
Kristen D Evans,
Langer,
Leonard H Lavi,
Liming Zhang,
Linda F Murphy,
Linda Thai,
Louis B Cencetti,
LT Richard A Lyght,
Marco S Esteves,
Marcus F Yambot,
Mark C Saale,
Matthew B Casale,
Matthew J Johnson,
Melanie M Walker,
Meyer J Slobotsky,
Michael D Garcia,
Michael F Schuette,
Mihaly S Ligmond,
Minh D Phan,
Nabeela J Chaudhry,
Nancy L Rolli,
Natalie J Ayoub,
Nelly N Tran,
Nibin Varghese, MS,
Nicholas L Hunt,
Noreen Muniz,
Patsy J Domingo,
Paul L Figarole, Jr,
Phillip L Toy,
Raymond T Oji,
Raymond W Brullo,
Rebecca Rodriguez,
Renee S Blosser,
Richard W Tubb,
Richmond K Yip,
Robert M Tillman,
Roger F Zabinski,
Russell J Glapion,
Sandra L Shire, DMD, MPA,
Sangeeta M Khurana, PhD,
Santiago Gallardo Johnson,
Sean P Desbrow,
Selene T Torres,
Sharon S Ho,
Shirnette D Ferguson,
Sidonie J Takougang,
Simone E Pitts,
Simone Pins,
Sonya L Karsik,
State Agency,
Stephanie A Slater, MS,
Stephen R Souza,
Steven B Hertz,
Sundy Ven,
Sunitha K Rajaram, PhD,
Susan M Jackson,
Susan P Bruederle,
Susant Hadman,
Tajah L Blackburn,
Tamala P Bogan,
Tamala P Magee,
Tammy Vasquez Hancock,
Temar Q Williams,
Terri L Dodds,
Thao T Kwan,
Thao X Tran,
That T Kwan,
Thomas E Friel,
Timothy P Lafave,
Tracey T Duong,
Truong Xuan Nguyen (Andy),
Uttaniti Limchumroon (Tom),
Virgilio F Pacio, CSO,
Vlada Matusovsky,
Walden H Lee,
William D Boden,
Yumi J Hiramine,
Yvonne C Wilkes
Donna Mwilliams Hill's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2006 | FDA 483 | Haemonetics Manufacturing Inc. - Form 483, 2006-05-23 |
September, 2009 | FDA 483 | TLC Labs, Inc. - Form 483, 2009-09-10 |
March, 2003 | FDA 483 | B. Braun Medical Inc. - Form 483, 2003-03-26 |
November, 2007 | FDA 483 Response | Patheon UK Limited - Form 483R, 2007-12-07 |
November, 2007 | EIR | Patheon UK Limited - EIR, 2007-11-09 |
November, 2007 | FDA 483 | Patheon UK Limited - Form 483, 2007-11-09 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more